We are live on ! Find out more
AORT icon

Artivion

239 hedge funds and large institutions have $1.63B invested in Artivion in 2026 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 94 increasing their positions, 66 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

42% more repeat investments, than reductions

Existing positions increased: 94 | Existing positions reduced: 66

1.7% more ownership

Funds ownership: 91.02%92.72% (+1.7%)

0% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 38

1% less funds holding

Funds holding: 242239 (-3)

17% less capital invested

Capital invested by funds: $1.97B → $1.63B (-$341M)

Holders
239
Holders Change
-3
Holders Change %
-1.24%
% of All Funds
2.94%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.04%
New
38
Increased
94
Reduced
66
Closed
38
Calls
$11K
Puts
Net Calls
+$11K
Net Calls Change
+$796K
Name Holding Trade Value Shares
Change
Change in
Stake
Charles Schwab
26
Charles Schwab
California
$14.9M -$63.3K -1,605 -0.4%
Invesco
27
Invesco
Georgia
$13.7M -$28.6M -726,193 -66%
PCM
28
Peregrine Capital Management
Minnesota
$12.6M +$1.86M +47,074 +16%
First Eagle Investment Management
29
First Eagle Investment Management
New York
$11.4M +$186K +4,708 +2%
Goldman Sachs
30
Goldman Sachs
New York
$11.2M -$9.12M -231,098 -43%
KCM
31
Kennedy Capital Management
Missouri
$11M -$5.5M -139,397 -32%
VFT
32
Vanguard Fiduciary Trust
Pennsylvania
$10.7M +$11.5M +292,301 New
Principal Financial Group
33
Principal Financial Group
Iowa
$9.57M +$825K +20,921 +9%
UBS Group
34
UBS Group
Switzerland
$9.41M -$898K -22,753 -8%
PHP
35
Parkman Healthcare Partners
Connecticut
$9.23M +$1.32M +33,345 +15%
Bank of New York Mellon
36
Bank of New York Mellon
New York
$8.88M -$165K -4,175 -2%
OCM
37
Osterweis Capital Management
California
$8.8M +$769K +19,490 +9%
OAM
38
Oberweis Asset Management
Illinois
$8.1M +$160K +4,062 +2%
Qube Research & Technologies (QRT)
39
Qube Research & Technologies (QRT)
United Kingdom
$7.37M +$7.16M +181,444 +913%
TI
40
Tidal Investments
Wisconsin
$7.06M -$194K -4,930 -2%
Ameriprise
41
Ameriprise
Minnesota
$7.02M +$1.99M +50,496 +36%
SCA
42
Summit Creek Advisors
Minnesota
$6.93M +$1.9M +48,264 +34%
Voloridge Investment Management
43
Voloridge Investment Management
Florida
$6.88M -$360K -9,124 -5%
Legal & General Group
44
Legal & General Group
United Kingdom
$6.78M -$224K -5,677 -3%
SEI Investments
45
SEI Investments
Pennsylvania
$6.15M +$2.12M +53,728 +47%
Lord, Abbett & Co
46
Lord, Abbett & Co
New Jersey
$6.08M -$16.5M -418,159 -72%
WA
47
Wasatch Advisors
Utah
$5.73M -$1.9M -48,055 -24%
First Trust Advisors
48
First Trust Advisors
Illinois
$5.54M +$587K +14,878 +11%
O
49
OrbiMed
New York
$5.53M +$5.96M +151,000 New
Public Sector Pension Investment Board (PSP Investments)
50
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$5.52M +$251K +6,355 +4%

AORT Hedge Fund Activity: Q1 2026 in Review

239 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Artivion (AORT) for Q1 2026, worth a combined $1.63B — down 17% from $1.97B a quarter earlier.

Fund positioning in AORT was balanced in Q1 2026: 38 funds opened new positions, 38 closed out, 94 added to existing stakes and 66 trimmed.

The largest buyer was Conestoga Capital Advisors, opening a new position worth an estimated $46.4M. The largest seller was Invesco, cutting an estimated $28.6M.

  • 239 institutional investors held Artivion (AORT) as of Q1 2026, down from 242 in Q4 2025.
  • Funds reported $1.63B of Artivion stock for Q1 2026, down 17% quarter-over-quarter.
  • 38 funds opened new Artivion positions in Q1 2026 and 38 closed out, a net change of 0 holders.
  • The largest Artivion buyer in Q1 2026 was Conestoga Capital Advisors, an estimated $46.4M added.
  • The largest Artivion seller in Q1 2026 was Invesco, an estimated $28.6M sold.

Based on aggregated 13F filings for Q1 2026.